Two abstracts include data generated in collaboration with Eli Lilly and Company and focusing on an AI-driven automated disease scoring technology aimed to accelerate clinical trials for ulcerative colitis
A plenary session will feature the first publicly available data from the clinical registration study on SKOUT™, the company’s automated polyp detection algorithm in colonoscopy, representing results from the largest, US-based clinical trial evaluating AI in colorectal cancer screening conducted to date.